Patient Capital Review – EISA response to the consultation paper and letter from Mark Brownridge
Re: Financing Growth in Innovative Companies– EISA response to the consultation paper
As the trade body that represents the EIS and SEIS industry, we felt it was important that you receive
a copy of our response to the above consultation.
The message that comes through loud and clear from reading the Patient Capital Review
consultation is that the Government has fairly substantial changes in its sights to ensure EIS and SEIS
are laser focused on high risk, early stage investment. If anything from our discussions with HMT in
the past few weeks, this message has only got louder and clearer. Read more here